Ad/Pd 2025. In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of. The ad/pd™ alzheimer’s disease and parkinson’s disease conference will present all the latest breakthroughs in treatment, translational r&d, early.

The ad/pd™ alzheimer’s disease and parkinson’s disease conference will present all the latest breakthroughs in treatment, translational r&d, early diagnosis, drug development and clinical trials in alzheimer’s, parkinson’s and. The ad/pd™ alzheimer’s disease and parkinson’s disease conference will present all the.